Trials / Completed
CompletedNCT05775744
Management of Postpartum Preeclampsia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 392 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the effect of a lower treatment threshold for antihypertensive medication and tighter blood pressure control, using remote blood pressure monitoring, on reducing Emergency Room visits for our postpartum patients with hypertensive disease.
Detailed description
The aim of this study is to assess the effect of lower treatment threshold for initiating antihypertensive medication and tighter blood pressure control, using remote blood pressure monitoring, on reducing Emergency Room visits for our postpartum patients with hypertensive disease. The investigators will study and compare two cohorts of patients. The first is a retrospective cohort, including patients delivered at Robert Wood Johnson University Hospital and Cooperman Barnabas Medical Center. The second is a prospective cohort that will enroll patients immediately postpartum who are eligible for our treatment protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Tight postpartum blood pressure control | The standard of care for patients with pregnancy induced hypertension is to start antihypertensive therapy if blood pressures are consistently over 150/100 mm Hg. There is no established standard of care for titrating blood pressure medication in the postpartum period for those with chronic hypertension and the approach to these patients varies by institution. The intervention in this study will be to start antihypertensive medications at a lower blood pressure cutoff, which is commonly used in the non-pregnant patient population to more tightly control blood pressure. Remote patient monitoring may be considered standard of care. The blood pressure targets chosen for this study are considered to be standard of care for non-pregnant people. |
Timeline
- Start date
- 2023-03-28
- Primary completion
- 2024-03-26
- Completion
- 2024-03-26
- First posted
- 2023-03-20
- Last updated
- 2024-04-02
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05775744. Inclusion in this directory is not an endorsement.